News

You are here:

Home
News

CORRECTING and REPLACING Tilray Exports First-Ever Commercial Shipment of Medical Cannabis Allowed into Israel

January 2, 2020

NANAIMO, British Columbia–(BUSINESS WIRE)–Please replace the release with the following corrected version due to multiple revisions. The corrected release reads: TILRAY EXPORTS FIRST-EVER COMMERCIAL SHIPMENT OF MEDICAL CANNABIS ALLOWED INTO ISRAEL Company signs 2.5 tonne strategic partnership agreement with Canndoc to address growing demand for medical cannabis products in Israeli market Export to Israel originates…

Details

Shareholder Alert: Robbins LLP Announces Trulieve Cannabis Corp. (TCNNF) Sued for Misleading Shareholders

January 2, 2020

SAN DIEGO & QUINCY, Fla.–(BUSINESS WIRE)–Shareholder rights law firm Robbins LLP announces that a purchaser of Trulieve Cannabis Corp. (OTC: TCNNF) filed a class action complaint for alleged violations of the Securities Exchange Act of 1934 between September 25, 2018 and December 17, 2019. Trulieve operates a medical marijuana company. If you suffered a loss…

Details

SOL Global Announces Director Resignation

January 3, 2020

TORONTO–(BUSINESS WIRE)–SOL Global Investments Corp. (“SOL Global”) (CSE:SOL) (OTCPK: SOLCF) (Frankfurt:9SB) announced today that Mr. Robert Reid, a Director of the Company, has stepped down from the Board of Directors effective January 3, 2020. Robert Reid said: “I would like to thank Brady and his team for the opportunity to sit on the board of…

Details

TRULIEVE CANNABIS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Trulieve Cannabis Corporation and Encourages Investors to Contact the Firm

January 3, 2020

NEW YORK–(BUSINESS WIRE)–Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, reminds investors that a class action lawsuit has been filed in the United States District Court for the Eastern District of New York on behalf of investors that purchased Trulieve Cannabis Corporation (Other OTC: TCNNF) securities between September 25, 2018 and December…

Details

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Trulieve Cannabis Corp. Investors

January 3, 2020

BENSALEM, Pa.–(BUSINESS WIRE)–Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (OTC: TCNNF) securities between September 25, 2018 and December 17, 2019, inclusive (the “Class Period”). Trulieve investors have until February 28, 2020 to file a…

Details

INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Trulieve Cannabis Corp. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

January 3, 2020

LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Trulieve Cannabis Corp. (“Trulieve” or “the Company”) (OTC: TCNNF) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.…

Details

Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Trulieve Cannabis Corp. Investors

January 3, 2020

LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a national investors rights law firm, announces that a class action lawsuit has been filed on behalf of investors that purchased Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (OTC: TCNNF) securities between September 25, 2018 and December 17, 2019, inclusive (the “Class Period”). Trulieve investors have until…

Details

Bophelo Partners with DNA Genetics in Lesotho

January 3, 2020

TORONTO–(BUSINESS WIRE)–Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that Bophelo Bioscience & Wellness (“Bophelo”) has signed a strategic alliance and seed purchase agreement with OG DNA Genetics Inc. (“DNA Genetics” or “DNA”), to give the Bophelo exclusive rights to develop new and existing DNA Genetics’…

Details

Organigram to Report First Quarter Fiscal 2020 Results on January 14th, 2020 and Operational Update

January 3, 2020

MONCTON, New Brunswick–(BUSINESS WIRE)–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its first quarter fiscal 2020 ended November 30, 2019 on Tuesday, January 14th after market close. The Company will host a…

Details

Can-Fite CEO Issues Letter to Shareholders

January 6, 2020

PETACH TIKVA, Israel–(BUSINESS WIRE)–Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, issued a Letter to Shareholders from the Company’s Chief Executive Officer, Pnina Fishman, Ph.D. Dear Can-Fite Shareholders, We made significant progress in our drug development programs during…

Details

Alpine Immune Sciences Announces Poster Presentation at 2020 Crohn’s & Colitis Congress

January 6, 2020

SEATTLE–(BUSINESS WIRE)–Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune/inflammatory diseases, today announced the company will present a poster at the 2020 Crohn’s & Colitis Congress taking place January 23-25, 2020, in Austin, Texas. Details of the presentation are as follows: Presentation Title: ALPN-101, A…

Details

Xtraction Services Announces Sale of Non-Essential Equipment and Buy-Back of 13.4% of XS’ Outstanding Shares

January 6, 2020

LOS ANGELES–(BUSINESS WIRE)–Xtraction Services Holding Corp., (“Xtraction Services”, “XS” or the “Company“) (CSE:XS) a specialty finance company engaged in equipment leasing in the United States, announced today that effective December 31, 2019, the Company has completed a transaction (the “Transaction”) with a vendor and former partner and its staff (together, the “Vendors”), whereby all of…

Details